{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T15:18:07Z","timestamp":1783523887956,"version":"3.55.0"},"reference-count":26,"publisher":"Oxford University Press (OUP)","issue":"7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,7,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Our Transplant Infectious Disease (TID) program implemented monitoring of all elevated bronchoalveolar lavage (BAL) galactomannan (GM) results as a quality improvement (QI) project. Twenty-four hours after a positive result, a standardized email is sent to the primary providers if the GM result is unaccounted for based on clinical documentation. We performed a real-world, retrospective study to examine the impact of this intervention over one year (2022\u20132023) as well as the impact of an elevated BAL GM result on clinical decision-making. We captured the number of positive GM results that triggered notification of the primary team, and the number of times a single positive galactomannan triggered initiation or change of systemic antifungal therapy. We included 55 cases of BAL GM &amp;gt;1.0. In seventeen cases (31%), a single positive BAL GM result triggered the initiation of antifungal therapy. Most of these cases met criteria for probable IPA. The TID team contacted the primary team for 14 cases (25%) of elevated BAL galactomannan antigens, which led to a new start or change in antifungal regimen. Voriconazole was the most common definitive antifungal agent chosen. Though elevated BAL GM results were impactful in introducing or changing antifungal regimens, we identified a possible knowledge gap in the interpretation of elevated galactomannan results among clinical staff. Our study suggests that there may be value in the diagnostic stewardship and monitoring of BAL galactomannan results by infectious disease clinicians.<\/jats:p>","DOI":"10.1093\/mmy\/myag069","type":"journal-article","created":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T22:50:40Z","timestamp":1782859840000},"source":"Crossref","is-referenced-by-count":0,"title":["The clinical utility of bronchoalveolar lavage galactomannan result stewardship within a tertiary medical system"],"prefix":"10.1093","volume":"64","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8874-0980","authenticated-orcid":false,"given":"Anna","family":"Apostolopoulou","sequence":"first","affiliation":[{"name":"Division of Infectious Diseases, Department of Medicine, New York Presbyterian\/Weill Cornell Medical Center , New York, New York ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4271-7443","authenticated-orcid":false,"given":"Sarah P","family":"Hammond","sequence":"additional","affiliation":[{"name":"MGH Transplant Center, Massachusetts General Hospital, Harvard Medical School , Boston, Massachusetts ,","place":["USA"]},{"name":"Division of Infectious Diseases, Massachusetts General Hospital, Harvard Medical School , Boston, Massachusetts ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3603-8110","authenticated-orcid":false,"given":"Sarah E","family":"Turbett","sequence":"additional","affiliation":[{"name":"MGH Transplant Center, Massachusetts General Hospital, Harvard Medical School , Boston, Massachusetts ,","place":["USA"]},{"name":"Division of Infectious Diseases, Massachusetts General Hospital, Harvard Medical School , Boston, Massachusetts ,","place":["USA"]},{"name":"Massachusetts General Hospital, Harvard Medical School Department of Pathology, , Boston, Massachusetts ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jay A","family":"Fishman","sequence":"additional","affiliation":[{"name":"MGH Transplant Center, Massachusetts General Hospital, Harvard Medical School , Boston, Massachusetts ,","place":["USA"]},{"name":"Division of Infectious Diseases, Massachusetts General Hospital, Harvard Medical School , Boston, Massachusetts ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2026,7,1]]},"reference":[{"issue":"6","key":"2026070810520530600_bib1","doi-asserted-by":"publisher","first-page":"1367","DOI":"10.1093\/cid\/ciz1008","article-title":"Revision and update of the consensus definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer and the Mycoses Study Group Education and Research Consortium","volume":"71","author":"Donnelly","year":"2020","journal-title":"Clin Infect Dis Off Publ Infect Dis Soc Am"},{"issue":"2","key":"2026070810520530600_bib2","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1016\/j.idc.2021.03.008","article-title":"Aspergillosis","volume":"35","author":"Cadena","year":"2021","journal-title":"Infect Dis Clin North Am."},{"issue":"2","key":"2026070810520530600_bib3","doi-asserted-by":"publisher","first-page":"252","DOI":"10.3390\/jof1020252","article-title":"Diagnostic modalities for invasive mould infections among hematopoietic stem cell transplant and solid organ recipients: performance characteristics and practical roles in the clinic","volume":"1","author":"Haidar","year":"2015","journal-title":"J Fungi"},{"issue":"10","key":"2026070810520530600_bib4","doi-asserted-by":"publisher","first-page":"1218","DOI":"10.1093\/cid\/cir185","article-title":"Comparison of an Aspergillus real-time polymerase chain reaction assay with galactomannan testing of bronchoalvelolar lavage fluid for the diagnosis of invasive pulmonary aspergillosis in lung transplant recipients","volume":"52","author":"Luong","year":"2011","journal-title":"Clin Infect Dis Off Publ Infect Dis Soc Am"},{"issue":"3","key":"2026070810520530600_bib5","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1097\/TP.0b013e3181e49bc1","article-title":"Diagnosis of invasive aspergillosis in lung transplant recipients by detection of galactomannan in the bronchoalveolar lavage fluid","volume":"90","author":"Pasqualotto","year":"2010","journal-title":"Transplantation"},{"issue":"12","key":"2026070810520530600_bib6","doi-asserted-by":"publisher","first-page":"1760","DOI":"10.1128\/CVI.00226-08","article-title":"Performance characteristics of the platelia Aspergillus enzyme immunoassay for detection of Aspergillus galactomannan antigen in bronchoalveolar lavage fluid","volume":"15","author":"Husain","year":"2008","journal-title":"Clin Vaccine Immunol"},{"issue":"4","key":"2026070810520530600_bib7","doi-asserted-by":"publisher","first-page":"1258","DOI":"10.1128\/jcm.06423-11","article-title":"Detection of galactomannan in bronchoalveolar lavage fluid samples of patients at risk for invasive pulmonary aspergillosis: analytical and clinical validity","volume":"50","author":"D\u2019Haese","year":"2012","journal-title":"J Clin Microbiol."},{"issue":"1","key":"2026070810520530600_bib8","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1183\/13993003.00583-2015","article-title":"Chronic pulmonary aspergillosis: rationale and clinical guidelines for diagnosis and management","volume":"47","author":"Denning","year":"2016","journal-title":"Eur Respir J."},{"issue":"6","key":"2026070810520530600_bib9","doi-asserted-by":"publisher","first-page":"e149","DOI":"10.1016\/S1473-3099(20)30847-1","article-title":"Defining and managing COVID-19-associated pulmonary aspergillosis: the 2020 ECMM\/ISHAM consensus criteria for research and clinical guidance","volume":"21","author":"Koehler","year":"2021","journal-title":"Lancet Infect Dis"},{"issue":"7","key":"2026070810520530600_bib10","doi-asserted-by":"publisher","first-page":"10.1128\/jcm.01784","DOI":"10.1128\/jcm.01784-20","article-title":"Recognition of diagnostic gaps for laboratory diagnosis of Fungal diseases: expert opinion from the Fungal Diagnostics Laboratories Consortium (FDLC)","volume":"59","author":"Zhang","year":"2021","journal-title":"J Clin Microbiol."},{"issue":"6","key":"2026070810520530600_bib11","doi-asserted-by":"publisher","first-page":"1759","DOI":"10.1128\/jcm.00077-07","article-title":"Bronchoalveolar lavage galactomannan in diagnosis of invasive pulmonary aspergillosis among solid-organ transplant recipients","volume":"45","author":"Clancy","year":"2007","journal-title":"J Clin Microbiol."},{"issue":"4","key":"2026070810520530600_bib12","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1093\/cid\/ciw326","article-title":"Practice Guidelines for the Diagnosis and Management of Aspergillosis: 2016 update by the Infectious Diseases Society of America","volume":"63","author":"Patterson","year":"2016","journal-title":"Clin Infect Dis."},{"issue":"12","key":"2026070810520530600_bib13","doi-asserted-by":"publisher","first-page":"1813","DOI":"10.1086\/588660","article-title":"Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer\/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC\/MSG) Consensus Group","volume":"46","author":"De\u00a0Pauw","year":"2008","journal-title":"Clin Infect Dis Off Publ Infect Dis Soc Am"},{"issue":"1","key":"2026070810520530600_bib14","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.jinf.2023.05.005","article-title":"Breakthrough invasive fungal infection among patients with haematologic malignancies: A national, prospective, and multicentre study","volume":"87","author":"Puerta-Alcalde","year":"2023","journal-title":"J Infect."},{"issue":"7","key":"2026070810520530600_bib15","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1097\/TP.0000000000000131","article-title":"Impact and cost of the serum galactomannan assay at a tertiary care facility","volume":"98","author":"Prasad","year":"2014","journal-title":"Transplantation"},{"issue":"12","key":"2026070810520530600_bib16","doi-asserted-by":"publisher","first-page":"1762","DOI":"10.1086\/429921","article-title":"Antifungal therapy decreases sensitivity of the Aspergillus galactomannan enzyme immunoassay","volume":"40","author":"Marr","year":"2005","journal-title":"Clin Infect Dis Off Publ Infect Dis Soc Am"},{"issue":"7","key":"2026070810520530600_bib17","doi-asserted-by":"publisher","first-page":"2475","DOI":"10.1128\/JCM.02693-05","article-title":"Characterization and comparison of galactomannan enzyme immunoassay and quantitative real-time PCR assay for detection of Aspergillus fumigatus in bronchoalveolar lavage fluid from experimental invasive pulmonary aspergillosis","volume":"44","author":"Francesconi","year":"2006","journal-title":"J Clin Microbiol."},{"issue":"3","key":"2026070810520530600_bib18","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1046\/j.1365-2141.2003.04308.x","article-title":"Galactomannan detection in computerized tomography-based broncho-alveolar lavage fluid and serum in haematological patients at risk for invasive pulmonary aspergillosis","volume":"121","author":"Becker","year":"2003","journal-title":"Br J Haematol."},{"key":"2026070810520530600_bib19","doi-asserted-by":"publisher","first-page":"1343","DOI":"10.15585\/mmwr.mm6938a2","article-title":"Public Awareness of invasive fungal diseases\u2014United States, 2019","volume":"69","author":"Benedict","year":"2020","journal-title":"MMWR Morb Mortal Wkly Rep."},{"issue":"10","key":"2026070810520530600_bib20","doi-asserted-by":"publisher","first-page":"880","DOI":"10.1001\/jama.2023.28019","article-title":"Prevalence of immunosuppression among US adults","volume":"331","author":"Martinson","year":"2024","journal-title":"JAMA"},{"key":"2026070810520530600_bib21","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1111\/ajt.12115","article-title":"AST Infectious Diseases Community of Practice. Aspergillosis in solid organ transplantation","volume":"13","author":"Singh","year":"2013","journal-title":"Am J Transplant Off J Am Soc Transplant Am Soc Transpl Surg"},{"issue":"8","key":"2026070810520530600_bib22","doi-asserted-by":"publisher","first-page":"1431","DOI":"10.1093\/cid\/ciac927","article-title":"Risk factors and outcomes of invasive aspergillosis in kidney transplant recipients: a case-control study of United States Renal Data System data","volume":"76","author":"Friedman","year":"2023","journal-title":"Clin Infect Dis Off Publ Infect Dis Soc Am"},{"issue":"12","key":"2026070810520530600_bib23","doi-asserted-by":"publisher","first-page":"e412","DOI":"10.1016\/S1473-3099(17)30308-0","article-title":"Improvement of fungal disease identification and management: combined health systems and public health approaches","volume":"17","author":"Cole","year":"2017","journal-title":"Lancet Infect Dis"},{"issue":"1","key":"2026070810520530600_bib24","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1007\/s11606-018-4659-4","article-title":"Use of computerized clinical decision support for diagnostic stewardship in Clostridioides difficile testing: an Academic hospital quasi-experimental study","volume":"34","author":"Friedland","year":"2019","journal-title":"J Gen Intern Med."},{"issue":"6","key":"2026070810520530600_bib25","doi-asserted-by":"publisher","first-page":"392","DOI":"10.12788\/jhm.2892","article-title":"The use of clinical decision support in reducing diagnosis of and treatment of asymptomatic bacteriuria","volume":"13","author":"Keller","year":"2018","journal-title":"J Hosp Med"},{"issue":"8","key":"2026070810520530600_bib26","doi-asserted-by":"publisher","first-page":"1524","DOI":"10.1007\/s00134-020-06091-6","article-title":"Review of influenza-associated pulmonary aspergillosis in ICU patients and proposal for a case definition: an expert opinion","volume":"46","author":"Verweij","year":"2020","journal-title":"Intensive Care Med."}],"container-title":["Medical Mycology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/mmy\/advance-article-pdf\/doi\/10.1093\/mmy\/myag069\/68665147\/myag069.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/mmy\/article-pdf\/64\/7\/myag069\/68665147\/myag069.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/mmy\/article-pdf\/64\/7\/myag069\/68665147\/myag069.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T14:52:14Z","timestamp":1783522334000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/mmy\/article\/doi\/10.1093\/mmy\/myag069\/8722923"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,1]]},"references-count":26,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2026,7,1]]}},"URL":"https:\/\/doi.org\/10.1093\/mmy\/myag069","relation":{},"ISSN":["1369-3786","1460-2709"],"issn-type":[{"value":"1369-3786","type":"print"},{"value":"1460-2709","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,7]]},"published":{"date-parts":[[2026,7,1]]},"article-number":"myag069"}}